Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024

Researchers target cancer's ability to survive at low oxygen levels

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute have shed light on how cancer cells survive in the first few hours after being cut off fr

Updated on: March 20,2024

Researchers target cancer's ability to survive at low oxygen levels

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute have shed light on how cancer cells survive in the first few hours after being cut off fr

Updated on:March 20,2024

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G

Updated on: March 30,2024

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G

Updated on:March 30,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on: January 12,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on:January 12,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on: September 10,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on:September 10,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on: March 30,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on:March 30,2024

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390

Updated on: December 01,2024

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390

Updated on:December 01,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on: June 01,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on:June 01,2024

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on: January 02,2024

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on:January 02,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on: February 23,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on:February 23,2024